Key points from article :
Insilico Medicine has emerged in the last few years as the face of AI drug discovery.
Designed and validated a drug candidate for treating fibrosis and other diseases in just 46 days.
First time anyone generative adversarial networks (GANs) and generative reinforcement learning AI techniques combined for drug discovery.
Could be pharma’s AlphaGo moment.
AI platform has advanced to where it could automate drug pipeline development from end to end.
Just announced a collaboration worth up to $200 million with Jiangsu Chia Tai Fenghai Pharmaceutical Co.
Company has about 16 ongoing collaborations.
CEO Alex Zhavoronkov believes “that there is nothing more important than longevity.”
